Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.
about
Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.Cancer stem cell theory and the warburg effect, two sides of the same coin?Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancerPretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients.Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinomaPrognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study.Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.Clinical characteristics and treatment options for two types of osteoblastoma in the mobile spine: a retrospective study of 32 cases and outcomes.An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.Pretreatment Alkaline Phosphatase and Epstein-Barr Virus DNA Predict Poor Prognosis and Response to Salvage Radiotherapy in Patients with Nasopharyngeal Carcinoma and Metachronous Bone-Only Metastasis.Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysisImportance of maintaining body weight for prevention of distant metastasis of nasopharyngeal carcinoma: An alternative workflow for cancer-risk assessment.High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma.Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma.A Prognostic Score for Nasopharyngeal Carcinoma with Bone Metastasis: Development and Validation from Multicenter.
P2860
Q33650637-F5E8641C-ACFB-4078-A1C0-35FE235799FEQ33755908-F6196FF5-577B-4808-8AD7-B9F395BA59EAQ34062252-E6A057EB-0DA8-4747-97E8-89197E763586Q36121373-24553C04-F8DF-414E-93EF-447DEACB669DQ36275495-5206BFC3-E10F-450E-BDCC-1E039A61850BQ36291469-37C4C896-3483-4DD7-A136-43D5DFC40F39Q37327988-186C7D6E-7825-4BC3-B48B-527FB65AE2A5Q37353991-08EC9E47-8A51-4C4F-8AE0-40AA537C1EB8Q37402090-2FCD46C6-686D-4DF2-A702-91D899374728Q37442510-549374B2-D9DB-404B-BFF8-3C772CE0AEA5Q37530631-A523FD8F-3008-4D83-B8C6-9CAC88D79431Q37609486-3B47C94D-567B-4DDF-A11C-7AD94E0ACBC1Q37621171-85EB2985-52AD-4AC2-8621-30A26687E608Q37675972-EB83923D-A6CA-4421-9D00-BCC7402612B8Q37719576-7D265910-4851-498F-A04C-D4DF77317B65Q37738086-201EF8C3-2C61-4BFA-B408-3D4319F28BCEQ37744341-9228E032-E62E-422D-AB05-0E70389757ABQ38487988-E08D9A81-ACCC-4A12-8CE8-DFCF057AA776Q38943596-7550787E-6BC5-4B31-B05E-2483AE15020BQ41441035-CCDAD3D2-3281-4BEA-8E22-3F7BE723B551Q42366562-C5648A17-D422-4AE5-A49F-B79E90498C31Q50857582-E17FF440-91B8-4E97-A715-9EC80BBE10E4Q52576032-C4A8E25F-16CC-4A0A-AB4F-6E1842588A0EQ52629271-FDA9854B-C235-4D92-B986-0E124AD10AC2
P2860
Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@en
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@nl
type
label
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@en
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@nl
prefLabel
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@en
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@nl
P2093
P2860
P356
P1476
Increased pretreatment levels ...... for nasopharyngeal carcinoma.
@en
P2093
Bing-Qing Xu
Mu-Sheng Zeng
Ya-Lan Tao
Yun-Fei Xia
Zhi-Gang Liu
P2860
P304
P356
10.5732/CJC.011.10283
P577
2012-01-09T00:00:00Z